Uniphar

H1 2026 results reflect 11% EPS growth

  • Sectors : Pharma and healthcare
  • Companies : Uniphar

Ratings and price correct at time of issue.

  • Uniphar

    Closing Price: 418c

  • RATING 27/08/19

  • PREVIOUS RATING N/A

Person's Name

Colin Grant

Analyst

DAVY VIEW

Uniphar provided a lot of the details on its H1 results in its July trading update. EPS growth of 11% is the standout metric, driven by strong organic growth in gross profit. The company is well positioned to achieve consensus EPS forecasts for FY2026. We leave our forecasts unchanged for now but see further upside.

View full article

Download full report with analyst certification and important disclosures

Sep 8 2026, 07:10 IST/BST

Download